世界の抗菌治療市場2020-2024

◆英語タイトル:Global Antimicrobial Therapeutics Market 2020-2024
◆商品コード:IRTNTR43391
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年5月2日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア太平洋、その他
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥312,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥416,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは抗菌治療の世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、用途別(抗ウイルス性、抗菌性、抗真菌性、駆虫性)分析、顧客状況、地域別状況、企業状況、企業分析などを総合的、多面的に調査・分析しました。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・抗菌治療の世界市場:用途別(抗ウイルス性、抗菌性、抗真菌性、駆虫性)
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Global Antimicrobial Therapeutics Market 2020-2024

Technavio has been monitoring the antimicrobial therapeutics market and it is poised to grow by $ 42.30 million during 2020-2024 progressing at a CAGR of 6% during the forecast period. Our reports on antimicrobial therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the recent drug approvals and robust pipeline, initiatives from government agencies, and rising awareness about microbial diseases. In addition, recent drug approvals and robust pipeline is anticipated to boost the growth of the market as well.

The antimicrobial therapeutics market analysis includes application segment and geographic landscapes
Technavio’s antimicrobial therapeutics market is segmented as below:
By Application
• Antiviral
• Antibacterial
• Antifungal
• Antiparasitic

By Geographic Landscapes
• North America
• Europe
• APAC
• ROW

This study identifies the increase in R&D of therapeutic vaccines as one of the prime reasons driving the antimicrobial therapeutics market growth during the next few years. Also, increased disease diagnostic modalities, and increasing research on combination therapies will lead to sizable demand in the market.
“Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our antimicrobial therapeutics market covers the following areas:
• Antimicrobial therapeutics market sizing
• Antimicrobial therapeutics market forecast
• Antimicrobial therapeutics market industry analysis”

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antimicrobial therapeutics market vendors that include AbbVie Inc., CSL Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., and Sanofi. Also, the antimicrobial therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/global-antimicrobial-therapeutics-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Application
o Market segments
o Comparison by Application
o Antiviral – Market size and forecast 2019-2024
o Antibacterial – Market size and forecast 2019-2024
o Antifungal – Market size and forecast 2019-2024
o Antiparasitic – Market size and forecast 2019-2024
o Market opportunity by Application
• Customer Landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o APAC – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Volume driver – Demand led growth
o Volume driver – External factors
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o AbbVie Inc.
o CSL Ltd.
o F. Hoffmann-La Roche Ltd.
o Gilead Sciences Inc.
o GlaxoSmithKline Plc
o Johnson & Johnson
o Merck & Co. Inc.
o Novartis AG
o Pfizer Inc.
o Sanofi
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2019 – 2024 ($ million)
• 13: Global market: Year-over-year growth 2019 – 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2019
• 21: Application – Market share 2019-2024 (%)
• 22: Comparison by Application
• 23: Antiviral – Market size and forecast 2019-2024 ($ million)
• 24: Antiviral – Year-over-year growth 2019-2024 (%)
• 25: Antibacterial – Market size and forecast 2019-2024 ($ million)
• 26: Antibacterial – Year-over-year growth 2019-2024 (%)
• 27: Antifungal – Market size and forecast 2019-2024 ($ million)
• 28: Antifungal – Year-over-year growth 2019-2024 (%)
• 29: Antiparasitic – Market size and forecast 2019-2024 ($ million)
• 30: Antiparasitic – Year-over-year growth 2019-2024 (%)
• 31: Market opportunity by Application
• 32: Customer landscape
• 33: Market share by geography 2019-2024 (%)
• 34: Geographic comparison
• 35: North America – Market size and forecast 2019-2024 ($ million)
• 36: North America – Year-over-year growth 2019-2024 (%)
• 37: Europe – Market size and forecast 2019-2024 ($ million)
• 38: Europe – Year-over-year growth 2019-2024 (%)
• 39: APAC – Market size and forecast 2019-2024 ($ million)
• 40: APAC – Year-over-year growth 2019-2024 (%)
• 41: ROW – Market size and forecast 2019-2024 ($ million)
• 42: ROW – Year-over-year growth 2019-2024 (%)
• 43: Key leading countries
• 44: Market opportunity by geography ($ million)
• 45: Impact of drivers and challenges
• 46: Vendor landscape
• 47: Landscape disruption
• 48: Industry risks
• 49: Vendors covered
• 50: Market positioning of vendors
• 51: AbbVie Inc. – Overview
• 52: AbbVie Inc. – Business segments
• 53: AbbVie Inc. – Key offerings
• 54: AbbVie Inc. – Key customers
• 55: AbbVie Inc. – Segment focus
• 56: CSL Ltd. – Overview
• 57: CSL Ltd. – Business segments
• 58: CSL Ltd. – Key offerings
• 59: CSL Ltd. – Key customers
• 60: CSL Ltd. – Segment focus
• 61: F. Hoffmann-La Roche Ltd. – Overview
• 62: F. Hoffmann-La Roche Ltd. – Business segments
• 63: F. Hoffmann-La Roche Ltd. – Key offerings
• 64: F. Hoffmann-La Roche Ltd. – Key customers
• 65: F. Hoffmann-La Roche Ltd. – Segment focus
• 66: Gilead Sciences Inc. – Overview
• 67: Gilead Sciences Inc. – Product and service
• 68: Gilead Sciences Inc. – Key offerings
• 69: Gilead Sciences Inc. – Key customers
• 70: Gilead Sciences Inc. – Segment focus
• 71: GlaxoSmithKline Plc – Overview
• 72: GlaxoSmithKline Plc – Business segments
• 73: GlaxoSmithKline Plc – Key offerings
• 74: GlaxoSmithKline Plc – Key customers
• 75: GlaxoSmithKline Plc – Segment focus
• 76: Johnson & Johnson – Overview
• 77: Johnson & Johnson – Business segments
• 78: Johnson & Johnson – Key offerings
• 79: Johnson & Johnson – Key customers
• 80: Johnson & Johnson – Segment focus
• 81: Merck & Co. Inc. – Overview
• 82: Merck & Co. Inc. – Business segments
• 83: Merck & Co. Inc. – Key offerings
• 84: Merck & Co. Inc. – Key customers
• 85: Merck & Co. Inc. – Segment focus
• 86: Novartis AG – Overview
• 87: Novartis AG – Business segments
• 88: Novartis AG – Key offerings
• 89: Novartis AG – Key customers
• 90: Novartis AG – Segment focus
• 91: Pfizer Inc. – Overview
• 92: Pfizer Inc. – Business segments
• 93: Pfizer Inc. – Key offerings
• 94: Pfizer Inc. – Key customers
• 95: Pfizer Inc. – Segment focus
• 96: Sanofi – Overview
• 97: Sanofi – Business segments
• 98: Sanofi – Key offerings
• 99: Sanofi – Key customers
• 100: Sanofi – Segment focus
• 101: Currency conversion rates for US$
• 102: Research Methodology
• 103: Validation techniques employed for market sizing
• 104: Information sources
• 105: List of abbreviations



【掲載企業】

AbbVie Inc., CSL Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の抗菌治療市場2020-2024]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆